Liver-specific MR imaging contrast agents

被引:55
作者
Hahn, PF
Saini, S
机构
[1] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA
关键词
D O I
10.1016/S0033-8389(05)70022-1
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Liver-specific MR imaging contrast agents consist of iron oxide particles or specially designed paramagnetic complexes targeting either the reticuloendothelial system of the liver or the hepatocytes. These agents enhance the relaxation of water molecules in normal liver tissue and are excluded from abnormal tissue, such as metastases. Relaxation enhancement provides a map of normal liver function, increasing conspicuity of focal abnormalities. Understanding the indications and use of these agents is a central challenge for radiologists practicing liver MR imaging.
引用
收藏
页码:287 / +
页数:13
相关论文
共 56 条
  • [1] MN-DPDP - ENHANCED MR-IMAGING OF MALIGNANT LIVER-LESIONS - EFFICACY AND SAFETY IN 20 PATIENTS
    AICHER, KP
    LANIADO, M
    KOPP, AF
    GRONEWALLER, E
    DUDA, SH
    CLAUSSEN, CD
    [J]. JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1993, 3 (05): : 731 - 737
  • [2] Results of a multicenter phase II clinical trial with a susceptibility contrast medium for magnetic resonance imaging of the liver
    Balzer, T
    Carter, EC
    Shamsi, K
    Niendorf, HP
    [J]. ACADEMIC RADIOLOGY, 1996, 3 : S417 - S419
  • [3] BARON RL, 1995, RADIOLOGY, V197, P415
  • [4] LIVER METASTASES - SAFETY AND EFFICACY OF DETECTION WITH SUPERPARAMAGNETIC IRON-OXIDE IN MR-IMAGING
    BELLIN, MF
    ZAIM, S
    AUBERTON, E
    SARFATI, G
    DURON, JJ
    KHAYAT, D
    GRELLET, J
    [J]. RADIOLOGY, 1994, 193 (03) : 657 - 663
  • [5] Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA) - Preliminary results of phase II clinical application
    Caudana, R
    Morana, G
    Pirovano, GP
    Nicoli, N
    Portuese, A
    Spinazzi, A
    DiRito, R
    Pistolesi, GF
    [J]. RADIOLOGY, 1996, 199 (02) : 513 - 520
  • [6] Uptake of mangafodipir trisodium (MnDPDP) by hepatocellular carcinoma: Correlation with unenhanced imaging findings and histopathologic features
    Chezmar, JL
    Redvanly, RD
    Sewell, CW
    [J]. ACADEMIC RADIOLOGY, 1996, 3 : S413 - S414
  • [7] CLEMENT O, 1992, INVEST RADIOL, V27, P612
  • [8] SOLUBLE-TYPE HEPATOBILIARY CONTRAST AGENTS FOR MR IMAGING
    DEHAEN, C
    GOZZINI, L
    [J]. JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1993, 3 (01): : 179 - 186
  • [9] SUPERPARAMAGNETIC IRON-OXIDE - DETECTION OF FOCAL LIVER-LESIONS AT HIGH-FIELD-STRENGTH MR-IMAGING
    DUDA, SH
    LANIADO, M
    KOPP, AF
    GRONEWALLER, E
    AICHER, KP
    PAVONE, P
    JEHLE, E
    CLAUSSEN, CD
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 1994, 4 (03) : 309 - 314
  • [10] Dysplastic nodules and hepatocellular carcinoma: Thin-section MR imaging of explanted cirrhotic livers with pathologic correlation
    Earls, JP
    Theise, ND
    Weinreb, JC
    DeCorato, DR
    Krinsky, GA
    Rofsky, NM
    Mizrachi, H
    Teperman, LW
    [J]. RADIOLOGY, 1996, 201 (01) : 207 - 214